Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1952 1
1954 2
1955 3
1957 2
1958 2
1959 1
1960 2
1961 3
1962 4
1963 5
1964 4
1965 7
1966 19
1967 7
1968 10
1969 15
1970 18
1971 15
1972 14
1973 15
1974 22
1975 16
1976 14
1977 17
1978 25
1979 30
1980 39
1981 25
1982 33
1983 37
1984 32
1985 40
1986 58
1987 52
1988 42
1989 76
1990 93
1991 87
1992 96
1993 99
1994 130
1995 122
1996 100
1997 104
1998 110
1999 122
2000 141
2001 134
2002 113
2003 158
2004 156
2005 167
2006 153
2007 134
2008 142
2009 154
2010 159
2011 185
2012 188
2013 183
2014 213
2015 189
2016 196
2017 186
2018 229
2019 236
2020 258
2021 260
2022 240
2023 198
2024 172

Text availability

Article attribute

Article type

Publication date

Search Results

5,854 results

Results by year

Filters applied: . Clear all
Page 1
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, Aoki T, Okami J, Yoshino I, Ito H, Okumura N, Yamaguchi M, Ikeda N, Wakabayashi M, Nakamura K, Fukuda H, Nakamura S, Mitsudomi T, Watanabe SI, Asamura H; West Japan Oncology Group and Japan Clinical Oncology Group. Saji H, et al. Among authors: yamaguchi m. Lancet. 2022 Apr 23;399(10335):1607-1617. doi: 10.1016/S0140-6736(21)02333-3. Lancet. 2022. PMID: 35461558 Clinical Trial.
Drosophila as a Model Organism.
Yamaguchi M, Yoshida H. Yamaguchi M, et al. Adv Exp Med Biol. 2018;1076:1-10. doi: 10.1007/978-981-13-0529-0_1. Adv Exp Med Biol. 2018. PMID: 29951811 Review.
Japanese guidelines for adult asthma 2020.
Nakamura Y, Tamaoki J, Nagase H, Yamaguchi M, Horiguchi T, Hozawa S, Ichinose M, Iwanaga T, Kondo R, Nagata M, Yokoyama A, Tohda Y; Japanese Society of Allergology. Nakamura Y, et al. Among authors: yamaguchi m. Allergol Int. 2020 Oct;69(4):519-548. doi: 10.1016/j.alit.2020.08.001. Epub 2020 Sep 4. Allergol Int. 2020. PMID: 32893125 Free article. Review.
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial.
Saura C, Oliveira M, Feng YH, Dai MS, Chen SW, Hurvitz SA, Kim SB, Moy B, Delaloge S, Gradishar W, Masuda N, Palacova M, Trudeau ME, Mattson J, Yap YS, Hou MF, De Laurentiis M, Yeh YM, Chang HT, Yau T, Wildiers H, Haley B, Fagnani D, Lu YS, Crown J, Lin J, Takahashi M, Takano T, Yamaguchi M, Fujii T, Yao B, Bebchuk J, Keyvanjah K, Bryce R, Brufsky A; NALA Investigators. Saura C, et al. Among authors: yamaguchi m. J Clin Oncol. 2020 Sep 20;38(27):3138-3149. doi: 10.1200/JCO.20.00147. Epub 2020 Jul 17. J Clin Oncol. 2020. PMID: 32678716 Free PMC article. Clinical Trial.
Exciting frontiers in drug hypersensitivity.
Yamaguchi M, Izuhara K. Yamaguchi M, et al. Allergol Int. 2019 Jul;68(3):287-288. doi: 10.1016/j.alit.2019.06.005. Allergol Int. 2019. PMID: 31266595 Free article. No abstract available.
Drosophila Charcot-Marie-Tooth Disease Models.
Yamaguchi M, Takashima H. Yamaguchi M, et al. Adv Exp Med Biol. 2018;1076:97-117. doi: 10.1007/978-981-13-0529-0_7. Adv Exp Med Biol. 2018. PMID: 29951817 Review.
Cancer-related genes and ALS.
Yamamoto I, Azuma Y, Yamaguchi M. Yamamoto I, et al. Among authors: yamaguchi m. Front Biosci (Landmark Ed). 2019 Jun 1;24(7):1241-1258. doi: 10.2741/4777. Front Biosci (Landmark Ed). 2019. PMID: 31136977 Free article. Review.
Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab-ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trial.
Shiraishi Y, Nomura S, Sugawara S, Horinouchi H, Yoneshima Y, Hayashi H, Azuma K, Hara S, Niho S, Morita R, Yamaguchi M, Yokoyama T, Yoh K, Kurata T, Okamoto H, Okamoto M, Kijima T, Kasahara K, Fujiwara Y, Murakami S, Kanda S, Akamatsu H, Takemoto S, Kaneda H, Kozuki T, Ando M, Sekino Y, Fukuda H, Ohe Y, Okamoto I. Shiraishi Y, et al. Among authors: yamaguchi m. Lancet Respir Med. 2024 Aug 16:S2213-2600(24)00185-1. doi: 10.1016/S2213-2600(24)00185-1. Online ahead of print. Lancet Respir Med. 2024. PMID: 39159638
Current treatment approaches for NK/T-cell lymphoma.
Yamaguchi M, Miyazaki K. Yamaguchi M, et al. J Clin Exp Hematop. 2017 Dec 27;57(3):98-108. doi: 10.3960/jslrt.17018. Epub 2017 Jul 6. J Clin Exp Hematop. 2017. PMID: 28679966 Free PMC article. Review.
Assessing the performance of the Cell Painting assay across different imaging systems.
Tromans-Coia C, Jamali N, Abbasi HS, Giuliano KA, Hagimoto M, Jan K, Kaneko E, Letzsch S, Schreiner A, Sexton JZ, Suzuki M, Trask OJ, Yamaguchi M, Yanagawa F, Yang M, Carpenter AE, Cimini BA. Tromans-Coia C, et al. Among authors: yamaguchi m. Cytometry A. 2023 Nov;103(11):915-926. doi: 10.1002/cyto.a.24786. Epub 2023 Oct 3. Cytometry A. 2023. PMID: 37789738 Free PMC article.
5,854 results